BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 18336269)

  • 1. Adaptor protein 3BP2 and cherubism.
    Hatani T; Sada K
    Curr Med Chem; 2008; 15(6):549-54. PubMed ID: 18336269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of B-cell receptor signaling by a point mutation of adaptor protein 3BP2 identified in human inherited disease cherubism.
    Ogi K; Nakashima K; Chihara K; Takeuchi K; Horiguchi T; Fujieda S; Sada K
    Genes Cells; 2011 Sep; 16(9):951-60. PubMed ID: 21794028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Point mutations of 3BP2 identified in human-inherited disease cherubism result in the loss of function.
    Miah SM; Hatani T; Qu X; Yamamura H; Sada K
    Genes Cells; 2004 Nov; 9(11):993-1004. PubMed ID: 15507112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adaptor protein 3BP2 is a potential ligand of Src homology 2 and 3 domains of Lyn protein-tyrosine kinase.
    Maeno K; Sada K; Kyo S; Miah SM; Kawauchi-Kamata K; Qu X; Shi Y; Yamamura H
    J Biol Chem; 2003 Jul; 278(27):24912-20. PubMed ID: 12709437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tyrosine phosphorylation of adaptor protein 3BP2 induces T cell receptor-mediated activation of transcription factor.
    Qu X; Kawauchi-Kamata K; Miah SM; Hatani T; Yamamura H; Sada K
    Biochemistry; 2005 Mar; 44(10):3891-8. PubMed ID: 15751964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of 3BP2 with SHP-1 regulates SHP-1-mediated production of TNF-α in RBL-2H3 cells.
    Chihara K; Nakashima K; Takeuchi K; Sada K
    Genes Cells; 2011 Dec; 16(12):1133-45. PubMed ID: 22077594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tyrosine phosphorylation of 3BP2 regulates B cell receptor-mediated activation of NFAT.
    Shukla U; Hatani T; Nakashima K; Ogi K; Sada K
    J Biol Chem; 2009 Dec; 284(49):33719-28. PubMed ID: 19833725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of Tankyrase-mediated destruction of 3BP2 is the underlying pathogenic mechanism of cherubism.
    Levaot N; Voytyuk O; Dimitriou I; Sircoulomb F; Chandrakumar A; Deckert M; Krzyzanowski PM; Scotter A; Gu S; Janmohamed S; Cong F; Simoncic PD; Ueki Y; La Rose J; Rottapel R
    Cell; 2011 Dec; 147(6):1324-39. PubMed ID: 22153076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tyrosine phosphorylation of 3BP2 is indispensable for the interaction with VAV3 in chicken DT40 cells.
    Chihara K; Kimura Y; Honjoh C; Yamauchi S; Takeuchi K; Sada K
    Exp Cell Res; 2014 Mar; 322(1):99-107. PubMed ID: 24406398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Syk-dependent tyrosine phosphorylation of 3BP2 is required for optimal FcRγ-mediated phagocytosis and chemokine expression in U937 cells.
    Chihara K; Kato Y; Yoshiki H; Takeuchi K; Fujieda S; Sada K
    Sci Rep; 2017 Sep; 7(1):11480. PubMed ID: 28904407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of FcepsilonRI-mediated degranulation by an adaptor protein 3BP2 in rat basophilic leukemia RBL-2H3 cells.
    Sada K; Miah SM; Maeno K; Kyo S; Qu X; Yamamura H
    Blood; 2002 Sep; 100(6):2138-44. PubMed ID: 12200378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased myeloid cell responses to M-CSF and RANKL cause bone loss and inflammation in SH3BP2 "cherubism" mice.
    Ueki Y; Lin CY; Senoo M; Ebihara T; Agata N; Onji M; Saheki Y; Kawai T; Mukherjee PM; Reichenberger E; Olsen BR
    Cell; 2007 Jan; 128(1):71-83. PubMed ID: 17218256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3BP2 adapter protein is required for receptor activator of NFκB ligand (RANKL)-induced osteoclast differentiation of RAW264.7 cells.
    GuezGuez A; Prod'homme V; Mouska X; Baudot A; Blin-Wakkach C; Rottapel R; Deckert M
    J Biol Chem; 2010 Jul; 285(27):20952-63. PubMed ID: 20439986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The adaptor protein 3BP2 associates with VAV guanine nucleotide exchange factors to regulate NFAT activation by the B-cell antigen receptor.
    Foucault I; Le Bras S; Charvet C; Moon C; Altman A; Deckert M
    Blood; 2005 Feb; 105(3):1106-13. PubMed ID: 15345594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The adaptor protein 3BP2 in leukocyte signaling].
    Deckert M
    Med Sci (Paris); 2006 Dec; 22(12):1081-6. PubMed ID: 17156730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myo1f, an Unconventional Long-Tailed Myosin, Is a New Partner for the Adaptor 3BP2 Involved in Mast Cell Migration.
    Navinés-Ferrer A; Ainsua-Enrich E; Serrano-Candelas E; Sayós J; Martin M
    Front Immunol; 2019; 10():1058. PubMed ID: 31143189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molecular and Cellular Pathogenesis of Cherubism].
    Ueki Y
    Clin Calcium; 2016 Jun; 26(6):918-26. PubMed ID: 27230848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The adaptor 3BP2 is required for early and late events in FcεRI signaling in human mast cells.
    Ainsua-Enrich E; Alvarez-Errico D; Gilfillan AM; Picado C; Sayós J; Rivera J; Martín M
    J Immunol; 2012 Sep; 189(6):2727-34. PubMed ID: 22896635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Jawing about TNF: new hope for cherubism.
    Novack DV; Faccio R
    Cell; 2007 Jan; 128(1):15-7. PubMed ID: 17218248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The adaptor 3BP2 is required for KIT receptor expression and human mast cell survival.
    Ainsua-Enrich E; Serrano-Candelas E; Álvarez-Errico D; Picado C; Sayós J; Rivera J; Martín M
    J Immunol; 2015 May; 194(9):4309-18. PubMed ID: 25810396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.